DE69728529D1 - Cytokinantagonisten und -agonisten - Google Patents

Cytokinantagonisten und -agonisten

Info

Publication number
DE69728529D1
DE69728529D1 DE69728529T DE69728529T DE69728529D1 DE 69728529 D1 DE69728529 D1 DE 69728529D1 DE 69728529 T DE69728529 T DE 69728529T DE 69728529 T DE69728529 T DE 69728529T DE 69728529 D1 DE69728529 D1 DE 69728529D1
Authority
DE
Germany
Prior art keywords
binding
csf
receptors
loop
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69728529T
Other languages
English (en)
Other versions
DE69728529T2 (de
Inventor
Angel Lopez
Christopher Bagley
Joanna Woodcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Application granted granted Critical
Publication of DE69728529D1 publication Critical patent/DE69728529D1/de
Publication of DE69728529T2 publication Critical patent/DE69728529T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69728529T 1996-01-30 1997-01-29 Cytokinantagonisten und -agonisten Expired - Lifetime DE69728529T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN780096 1996-01-30
AUPN7800A AUPN780096A0 (en) 1996-01-30 1996-01-30 Cytokine antagonists and agonists
PCT/AU1997/000049 WO1997028190A1 (en) 1996-01-30 1997-01-29 Cytokine antagonists and agonists

Publications (2)

Publication Number Publication Date
DE69728529D1 true DE69728529D1 (de) 2004-05-13
DE69728529T2 DE69728529T2 (de) 2005-04-14

Family

ID=3792117

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728529T Expired - Lifetime DE69728529T2 (de) 1996-01-30 1997-01-29 Cytokinantagonisten und -agonisten

Country Status (7)

Country Link
US (2) USRE39433E1 (de)
EP (2) EP0889905B1 (de)
JP (1) JP2000505420A (de)
AT (1) ATE263783T1 (de)
AU (1) AUPN780096A0 (de)
DE (1) DE69728529T2 (de)
WO (1) WO1997028190A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001511649A (ja) * 1997-02-07 2001-08-14 トーマス・ジェファーソン・ユニバーシティ サイトカインレセプターガンマ鎖のペプチド模倣物
AU9289098A (en) * 1997-09-23 1999-04-12 Astra Aktiebolag Inhibitors of hematopoietins interleukin-3, interleukin-5 and granulocyte/macrophage colony stimulating factor and uses thereof
CA2235420A1 (en) * 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
AUPP525198A0 (en) * 1998-08-13 1998-09-03 Medvet Science Pty. Ltd. Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
JP2002541061A (ja) 1999-02-08 2002-12-03 メドベット・サイエンス・プロプライエタリー・リミテッド サイトカイン結合ドメイン
EP1216037A2 (de) 1999-09-21 2002-06-26 Emory University Verfahren und zusammensetzungen zur behandlung von bluttplätchen-zusammenhängenden krankheiten, mit mpl hemmenden agenten
US7455836B2 (en) 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US8062637B2 (en) 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
US20060216757A1 (en) * 2003-04-25 2006-09-28 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
WO2006045202A1 (en) 2004-10-29 2006-05-04 Topigen Pharmaceuticals Inc. Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
KR101481844B1 (ko) * 2006-03-27 2015-01-13 메디뮨 리미티드 Ｇｍ-ｃｓｆ 수용체에 대한 결합 성분
WO2008085963A1 (en) * 2007-01-05 2008-07-17 University Of Florida Research Foundation, Inc. Materials and methods for the detection, prevention and treatment of autoimmune disease
US20100260744A1 (en) * 2007-07-11 2010-10-14 Medvet Science Pty Ltd. Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor
TW200918553A (en) 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
US20100209341A1 (en) * 2009-02-18 2010-08-19 Csl Limited Treatment of chronic inflammatory conditions
WO2013072901A2 (en) * 2011-11-17 2013-05-23 Btm Mazowsze Sp. Zo.O. Compositions and methods for treating glioma
WO2013090989A1 (en) 2011-12-22 2013-06-27 Csl Limited Method of treating inflammatory bowel disease
KR101676690B1 (ko) * 2015-08-04 2016-11-16 (주) 에빅스젠 Vegf 유도-혈관신생 억제효과를 갖는 테트라펩티드 및 이의 용도
TWI824372B (zh) * 2015-10-12 2023-12-01 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白

Also Published As

Publication number Publication date
DE69728529T2 (de) 2005-04-14
JP2000505420A (ja) 2000-05-09
US6200567B1 (en) 2001-03-13
EP0889905A4 (de) 2000-06-07
ATE263783T1 (de) 2004-04-15
EP0889905A1 (de) 1999-01-13
EP0889905B1 (de) 2004-04-07
WO1997028190A1 (en) 1997-08-07
AUPN780096A0 (en) 1996-02-22
EP1386933A1 (de) 2004-02-04
USRE39433E1 (en) 2006-12-19

Similar Documents

Publication Publication Date Title
ATE263783T1 (de) Cytokinantagonisten und -agonisten
US4888023B1 (en) Femoral prosthesis with uncoupled distal tip
LU91449I2 (fr) "panitumumab en combinaison avec un agent anti-néoplastique"
DE69233188D1 (de) Hormonanaloge mit mehreren ctp-erweiterungen
FI911319A0 (fi) Polypeptidderivat.
ATE304864T1 (de) Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
NO20000086D0 (no) Chimerisk interleukin-6 opploeselig reseptor/ligandprotein, analoger derav og anvendelse av dette
DE69131699T2 (de) Verändertes menschliches iL-6
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
HUP0002831A3 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
DE68906771D1 (de) Verankerungsvorrichtung fuer knieprothese.
AU2002311556A1 (en) Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
EP0556171A4 (de) Antagonisten von wachstumshormonen.
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
ATE58838T1 (de) Mittel mit kontinuierlicher peptidfreisetzung.
AU6826487A (en) Surgery for strengthening tendon in horses leg
DE29706541U1 (de) Verbesserung des Einspritzgeräts der künstlichen Befruchtung für Sau
ZA92586B (en) Composition of antibodies directed towards the human or animal interleukin-2 receptor
DE59207735D1 (de) Neues thrombininhibitorisches protein aus zecken
IT220481Z2 (it) Perno sfilabile per l'impiego per la realizzazione di protesi dentarie di tipo fisso
IT8534077V0 (it) Protesi sostitutiva dell'articolazione metacarpo-falangea ed interfalangea della mano.
FI20000833A (fi) Kasvainkuoliotekijä-alfa- ja kasvainkuoliotekijä-beta- reseptoreita
IT8434069V0 (it) Componente femorale di impianto protesico sostitutivo dell'articolazione coxo-femorale.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition